0001209191-20-001775.txt : 20200106
0001209191-20-001775.hdr.sgml : 20200106
20200106161852
ACCESSION NUMBER: 0001209191-20-001775
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YOUNG WILLIAM D
CENTRAL INDEX KEY: 0001217420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20509935
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001217420
YOUNG WILLIAM D
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2020-01-02
4
M
0
20000
72.14
A
29311
D
Common Stock
2020-01-02
4
S
0
2500
217.72
D
26811
D
Common Stock
2020-01-02
4
S
0
7266
218.73
D
19545
D
Common Stock
2020-01-02
4
S
0
10134
219.37
D
9411
D
Common Stock
2020-01-02
4
S
0
100
220.08
D
9311
D
Stock Option (Right to Buy)
72.14
2020-01-02
4
M
0
20000
0.00
D
2024-05-31
Common Stock
20000
0
D
Transaction made pursuant to Mr. Young's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $217.72 (range $217.08 to $218.06).
Mr. Young undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $218.73 (range $218.08 to $219.07).
Open market sales reported on this line occurred at a weighted average price of $219.37 (range $219.08 to $219.78).
Fully vested.
/s/ Omar White, Attorney-in-Fact
2020-01-06